A Pan-Cancer Analysis of UBE2S in Tumorigenesis, Prognosis, Pathway, Immune Infiltration and Evasion, and Therapy Response from an Immune-Oncology Perspective

<div>Enrichment analyses and visualization of UBE2S-related partners based on TCGA dataset. UBE2S-related signaling pathways were determined by GSVA (a) and GSEA (b) algorithms, respectively, in pan-cancers. GSVA: Gene Set Variation Analysis; GSEA: Gene Set Enrichment Analysis.</div>

Journal of Oncology

fig5

Figure 5

Figure 5: A Pan-Cancer Analysis of UBE2S in Tumorigenesis, Prognosis, Pathway, Immune Infiltration and Evasion, and Therapy Response from an Immune-Oncology Perspective 

Figure 5 | A Pan-Cancer Analysis of UBE2S in Tumorigenesis, Prognosis, Pathway, Immune Infiltration and Evasion, and Therapy Response from an Immune-Oncology Perspective 